Last reviewed · How we verify

Chinese DT vaccine

GlaxoSmithKline · Phase 3 active Biologic

Chinese DT vaccine is a Toxoid vaccine Biologic drug developed by GlaxoSmithKline. It is currently in Phase 3 development for Prevention of diphtheria and tetanus in pediatric and adult populations. Also known as: Boostrix.

The Chinese DT vaccine stimulates the immune system to produce antibodies and cellular immunity against diphtheria and tetanus toxins.

The Chinese DT vaccine stimulates the immune system to produce antibodies and cellular immunity against diphtheria and tetanus toxins. Used for Prevention of diphtheria and tetanus in pediatric and adult populations.

At a glance

Generic nameChinese DT vaccine
Also known asBoostrix
SponsorGlaxoSmithKline
Drug classToxoid vaccine
ModalityBiologic
Therapeutic areaImmunology
PhasePhase 3

Mechanism of action

This is a toxoid-based vaccine containing inactivated diphtheria and tetanus toxins that have been chemically treated to eliminate their toxicity while preserving immunogenicity. The vaccine trains the adaptive immune system to recognize and neutralize diphtheria and tetanus toxins, providing protection against these bacterial diseases through both humoral (antibody) and cell-mediated immune responses.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Chinese DT vaccine

What is Chinese DT vaccine?

Chinese DT vaccine is a Toxoid vaccine drug developed by GlaxoSmithKline, indicated for Prevention of diphtheria and tetanus in pediatric and adult populations.

How does Chinese DT vaccine work?

The Chinese DT vaccine stimulates the immune system to produce antibodies and cellular immunity against diphtheria and tetanus toxins.

What is Chinese DT vaccine used for?

Chinese DT vaccine is indicated for Prevention of diphtheria and tetanus in pediatric and adult populations.

Who makes Chinese DT vaccine?

Chinese DT vaccine is developed by GlaxoSmithKline (see full GlaxoSmithKline pipeline at /company/gsk).

Is Chinese DT vaccine also known as anything else?

Chinese DT vaccine is also known as Boostrix.

What drug class is Chinese DT vaccine in?

Chinese DT vaccine belongs to the Toxoid vaccine class. See all Toxoid vaccine drugs at /class/toxoid-vaccine.

What development phase is Chinese DT vaccine in?

Chinese DT vaccine is in Phase 3.

What are the side effects of Chinese DT vaccine?

Common side effects of Chinese DT vaccine include Injection site pain, redness, or swelling, Fever, Myalgia, Fatigue.

Related